Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (47)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nickeleit, V.
Right arrow Articles by Mihatsch, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nickeleit, V.
Right arrow Articles by Mihatsch, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 2232-2239
© 2003 European Renal Association-European Dialysis and Transplant Association


Invited Comment

Kidney transplants, antibodies and rejection: is C4d a magic marker?

Volker Nickeleit1 and Michael J. Mihatsch2

1Nephropathology Laboratory, Department of Pathology, University of North Carolina, Chapel Hill, NC, USA and 2Institute for Pathology, University of Basel, Switzerland

Correspondence and offprint requests to: Volker Nickeleit, MD, Nephropathology Laboratory, Department of Pathology, University of North Carolina, Campus Box 7525, Chapel Hill, NC 27599-7525, USA. Email: volker_nickeleit{at}med.unc.edu

Abstract

The immunohistochemical detection of the complement degradation product C4d in renal allograft biopsies has gained considerable clinical interest in recent years. The accumulation of C4d along peritubular capillaries is generally regarded as a marker for an antibody-mediated allo-response and is associated with poor graft survival. The aim of this review is to discuss histological findings associated with the deposition of C4d. Emphasis is placed on diagnostic and therapeutic implications. Unanswered questions regarding C4d and graft injury are highlighted.

Keywords: antibodies; C4d; diagnosis; rejection; therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
P. Ranjan, R. Nada, V. Jha, V. Sakhuja, and K. Joshi
The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1735 - 1741.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Dragun and B. Rudolph
Novelties in diagnostics and therapy of antibody mediated rejection
Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_8): viii50 - viii53.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Dragun
Agonistic antibody-triggered stimulation of Angiotensin II type 1 receptor and renal allograft vascular pathology
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1819 - 1822.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. A. Seemayer, A. Gaspert, V. Nickeleit, and M. J. Mihatsch
C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 568 - 576.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
P. L. Zhang, S. K. Malek, T. M. Blasick, J. R. Pennington, K. K. Masker, M. Lun, and S. Potdar
C4d Positivity Is Often Associated with Acute Cellular Rejection in Renal Transplant Biopsies Following Campath-1H (Alemtuzumab) Induction
Ann. Clin. Lab. Sci., January 1, 2007; 37(2): 121 - 126.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Imai, S. Nishi, B. Alchi, M. Ueno, S. Fukase, M. Arakawa, K. Saito, K. Takahashi, and F. Gejyo
Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2589 - 2595.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. B. Magil and K. J. Tinckam
Focal peritubular capillary C4d deposition in acute rejection
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1382 - 1388.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. L. Troxell, L. A. Weintraub, J. P. Higgins, and N. Kambham
Comparison of C4d Immunostaining Methods in Renal Allograft Biopsies
Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 583 - 591.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Q. Sun, Z.-H. Liu, G. Yin, H. Chen, J. Chen, S. Ji, and L.-S. Li
Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients
Nephrol. Dial. Transplant., February 1, 2006; 21(2): 510 - 517.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. R. Ingelfinger
Agonistic Autoantibodies and Rejection of Renal Allografts
N. Engl. J. Med., February 10, 2005; 352(6): 617 - 619.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.